Cargando…

Increased taurine in pre-weaned juvenile mdx mice greatly reduces the acute onset of myofibre necrosis and dystropathology and prevents inflammation

Background: The mdx mouse model for the fatal muscle wasting disease Duchenne Muscular Dystrophy (DMD) shows a very mild pathology once growth has ceased, with low levels of myofibre necrosis in adults. However, from about 3 weeks of post-natal age, muscles of juvenile mdx mice undergo an acute bout...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terrill, Jessica R., Grounds, Miranda D, Arthur, Peter G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Muscular Dystrophy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029885/ https://www.ncbi.nlm.nih.gov/pubmed/27679740 http://dx.doi.org/10.1371/currents.md.77be6ec30e8caf19529a00417614a072

Ejemplares similares

The different impact of a high fat diet on dystrophic mdx and control C57Bl/10 mice.
por: Radley-Crabb, Hannah G, et al.
Publicado: (2011)

Alterations in the expression of leukemia inhibitory factor following exercise: comparisons between wild-type and mdx muscles
por: Hunt, Liam C, et al.
Publicado: (2011)

Voluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotype
por: Smythe, Gayle M, et al.
Publicado: (2012)

Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages
por: Wang, Bo, et al.
Publicado: (2011)

Health Care Transition Experiences of Males with Childhood-onset Duchenne and Becker Muscular Dystrophy: Findings from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) Health Care Transitions and Other Life Experiences Survey
por: Paramsothy, Pangaja, et al.
Publicado: (2018)

Repression of nuclear CELF activity can rescue CELF-regulated alternative splicing defects in skeletal muscle models of myotonic dystrophy
por: Berger, Dara S., et al.
Publicado: (2012)

DuchenneConnect Registry Report
por: Rangel, Vanessa, et al.
Publicado: (2012)

Speckle tracking analysis of the left ventricular anterior wall shows significantly decreased relative radial strain patterns in dystrophin deficient mice after 9 months of age
por: Spurney, Christopher, et al.
Publicado: (2012)

Restoration of dystrophin expression using the Sleeping Beauty transposon
por: Muses, Sofia, et al.
Publicado: (2012)

Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences
por: Henricson, Erik, et al.
Publicado: (2012)

The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish
por: Winder, Steve J, et al.
Publicado: (2011)

Intramuscular Transplantation of Muscle Precursor Cells over-expressing MMP-9 improves Transplantation Success
por: Pichavant, Christophe, et al.
Publicado: (2011)

Human satellite cells: identification on human muscle fibres
por: Boldrin, Luisa, et al.
Publicado: (2012)

Dysferlin-deficient immortalized human myoblasts and myotubes as a useful tool to study dysferlinopathy
por: Philippi, Susanne, et al.
Publicado: (2012)

Clinic-Based Infant Screening for Duchenne Muscular Dystrophy: A Feasibility Study
por: Cyrus, Alissa, et al.
Publicado: (2012)

Guidance in Social and Ethical Issues Related to Clinical, Diagnostic Care and Novel Therapies for Hereditary Neuromuscular Rare Diseases: “Translating“ the Translational
por: McCormack, Pauline, et al.
Publicado: (2013)

The 6 Minute Walk Test and Performance of Upper Limb in Ambulant Duchenne Muscular Dystrophy Boys
por: Pane, Marika, et al.
Publicado: (2014)

Validity, Reliability, and Sensitivity of a 3D Vision Sensor-based Upper Extremity Reachable Workspace Evaluation in Neuromuscular Diseases
por: Han, Jay J., et al.
Publicado: (2013)

The Effect of 6-Thioguanine on Alternative Splicing and Antisense-Mediated Exon Skipping Treatment for Duchenne Muscular Dystrophy
por: Verhaart, Ingrid E. C., et al.
Publicado: (2012)

The Effects of Glucocorticoid and Voluntary Exercise Treatment on the Development of Thoracolumbar Kyphosis in Dystrophin-Deficient Mice
por: Brereton, Daniel, et al.
Publicado: (2012)

Proof of Concept of the Ability of the Kinect to Quantify Upper Extremity Function in Dystrophinopathy
por: Lowes, Linda P, et al.
Publicado: (2013)

Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice
por: Spitali, Pietro, et al.
Publicado: (2013)

New Recommendation on Biological Materials Could Hamper Muscular Dystrophy Research
por: McCormack, Pauline, et al.
Publicado: (2016)

Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life?
por: Sienko, Susan, et al.
Publicado: (2016)

Investigating Synthetic Oligonucleotide Targeting of Mir31 in Duchenne Muscular Dystrophy
por: Hildyard, John CW, et al.
Publicado: (2016)

Are Soy Products Effective in DMD?
por: Winder, Steve J, et al.
Publicado: (2018)

Collective Statement Regarding Patient Access to Approved Therapies from the Center Directors of Parent Project Muscular Dystrophy’s Certified Duchenne Care Centers
por: Ionita, Cristian, et al.
Publicado: (2018)

A Pilot Survey Study of Adherence to Care Considerations for Duchenne Muscular Dystrophy
por: Conway, Kristin, et al.
Publicado: (2018)

Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
por: Larkindale, Jane, et al.
Publicado: (2017)

Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction
por: Terrill, Jessica R., et al.
Publicado: (2017)

Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy
por: Terrill, Jessica R., et al.
Publicado: (2020)

Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy
por: Radley-Crabb, Hannah G., et al.
Publicado: (2014)

Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy
por: Terrill, Jessica R., et al.
Publicado: (2016)

Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the mdx Mouse Model for Duchenne Muscular Dystrophy
por: Terrill, Jessica R., et al.
Publicado: (2023)

Benefits of Prenatal Taurine Supplementation in Preventing the Onset of Acute Damage in the Mdx Mouse
por: Barker, Robert G., et al.
Publicado: (2017)

A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
por: Al-Mshhdani, Basma A., et al.
Publicado: (2021)

Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology
por: Bencze, Maximilien
Publicado: (2022)

Diseases of skeletal muscle /
Publicado: (2000)

Global gene expression in muscle from fasted/refed trout reveals up-regulation of genes promoting myofibre hypertrophy but not myofibre production
por: Rescan, Pierre-Yves, et al.
Publicado: (2017)

Studies of pseudohypertrophic muscular dystrophy
por: Bonsett, Charles A., 1921-
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_i3t0ofvg2jn3dmurm97r94go4e